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Objectives: The objectives of this study were to investigate variations between states and changes in state-specific carotid
endarterectomy (CEA) and 30-day mortality rates. Cross-sectional variations and changes over time in such measures may
be indicative of improvement in the quality of care.
Methods: We performed retrospective analyses of pre-existing administrative data on Medicare beneficiaries aged 65 years
and older in the United States. Age-adjusted, state-specific CEA rates and 30-day postoperative mortality rates in 1991,
1995 and 2000 were examined, as well as changes in these rates from 1991 to 1995 and from 1995 to 2000. Stroke
mortality in the general population of each state was used as a crude measure of the need for CEA procedure in the state.
The Spearman rank correlation analysis was used to study correlations between rates. Oldham’s method was used to avoid
the effect of regression to the mean.
Results: There were wide variations in the state-specific CEA rates, 30-day mortality, and in changes in these rates over
time. The states with relatively low procedure rates in 1991 also had low rates in 1995 and 2000, and relatively higher
increases in the rates. The states with relatively high 30-day mortality in 1991 or 1995 had lower increases or greater
decreases in the rate. CEA rates were not correlated with any measure of surgical mortality, but they were correlated with
stroke mortality in the general population.
Conclusions: The inter-state variation in CEA rates has not changed much since 1991, but variation in 30-day mortality
decreased through 2000. The states with low procedure rates in 1991 did not have sufficient increase to catch up with the
high-rate states by 1995, but they were prone to experience a higher increase in the subsequent 5 years. The validity of
stroke mortality in a state as a measure of the need for CEA is questionable. Further research using clinical data is needed
to better explain variations between states. (J Vasc Surg 2003;38:779-84.)
Endarterectomy for symptomatic carotid artery steno-
sis has been practiced for nearly 50 years to prevent ipsilat-
eral ischemic stroke.1 The appropriateness of this proce-
dure received attention in the mid-1980s in view of its
serious complications, stroke and death in particular.2-4 As
a result of better diagnostic and surgical skills, carotid
endarterectomy (CEA) was also performed on asymptom-
atic patients.5 During this period, many case studies, obser-
vational studies, and controlled trials have been conducted
to evaluate the benefits of CEA, and many articles, reviews,
and editorials have been published in the medical journals.
For example, two trials concluded that CEA was beneficial
for selected patients with symptomatic and asymptomatic
stenosis.6,7 At the same time, many studies have addressed
the serious complications and adverse outcomes of the
procedure.5 These outcomes have usually been measured in
terms of in-hospital or 30-day mortality and stroke rates.
Several investigators have reported increasing use of
CEA in the mid-1980s and early 1990s, decreasing mortal-
ity attributed to the procedure, and sex differences in use
and mortality.8-15 A common goal of some of these obser-
vational studies was to investigate the effects on subsequent
use of CEA of the results of randomized controlled trials of
CEA published between 1991 and 1995. However, none
of these studies examined the trends and geographical
differences beyond 1996, and most of the studies were
limited to select populations and/or brief observation pe-
riods. A recent epidemiologic study of Medicare beneficia-
ries16 found that from 1991 to 1995, CEA use in the
United States increased 70% and 30-day postoperative
mortality decreased. Thereafter, there was a small decrease
in both rates. Small differences in CEA rates in 3 years
between Northeast and Southern regions were the only
regional differences found in the study. Variations between
individual health care providers or groups of providers, or
between geographic areas, with respect to use and adverse
outcomes are often useful determinants of the quality of
care. The objectives of this study were to use a 100% sample
of Medicare inpatient claims data to examine cross-
sectional variations in state-specific CEA use rates and
30-day postoperative mortality, and to study changes in
these rates over 10 years.
METHODS
The study population comprised all Medicare benefi-
ciaries residing in nonterritorial regions of the United
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States, who were aged 65 years and older and enrolled in
the fee-for-service sector. The International Classification
of Diseases, 9th Revision, Clinical Modification (ICD-9-
CM) procedure code for CEA (38.12) was used to identify
hospitalizations for CEA during the period 1991 through
2000 from the Centers for Medicare & Medicaid Services’
Medicare Provider Analysis and Review (MedPAR) file.
The CEA procedures were excluded if (1) the procedure
date was missing or appeared to be in error, (2) hospital-
ization for a second CEA occurred within 30 days, or (3)
coronary artery bypass graft (CABG) surgery was per-
formed during the same hospital stay. (Surgical mortality
following CEA is known to be much higher if CABG is
performed during the same hospital stay; and a patient has
to survive the first CEA to have a second procedure within
30 days. Consequently, 30-day mortality following the
second CEA was used in the analyses.) All causes mortality
among CEA cases was ascertained from the Medicare mor-
tality file and included in the study if the date of death was
within 30 days from the date of the procedure. The CEA
and surgical mortality rates were adjusted for age by using
the direct standardization method17 and the 1991 US
Medicare beneficiary population as the standard. All CEA
rates described here are the number of procedures per 1000
beneficiaries, and the 30-day mortality rates are the number
of deaths per 100 procedures. The data on the annual
state-specific stroke mortality per 100,000 general popula-
tion were downloaded from the Web site of the National
Center for Health Statistics. This variable was used as an
indicator of the risk of stroke and the need for CEA,
preventive measure, in the general population. The state
code for beneficiaries’ residence was used to stratify the data
by state.
Complete MedPAR data were available for the years
1991 through 2000, and CEA rates had peaked in 1995.16
Consequently, three “points” in time—1991, 1995, and
2000—were chosen to study changes over time. The state-
specific rates in 1 year were compared with those in the
other year and with the percent change in the rate during
the period. Twelve state-specific measures of the frequency
of CEA procedures and mortality were used in the correla-
tion analyses. These variables were the procedure rates in
1991, 1995, and 2000; 30-day mortality rates for the same
3 years; percent change in the procedure and mortality rates
from 1991 to 1995, and from 1995 to 2000; and stroke
mortality in the general population in 1991 and in 1999. If
two or more of these measures for a state were zero, the
state was excluded from the analyses. Accordingly, the
District of Columbia and the State of Alaska were excluded.
Because the values of most of the variables were not
normally distributed and their scatter plots were not ellip-
tical, the Spearman rank order correlation analysis method
in the SAS software (Version 6, SAS Institute Inc, Cary,
NC) was used. In order to avoid the possible effect of
regression to the mean, Oldham’s method18 of correlation
analysis was used to study the relationship between CEA
rates or 30-day mortality rates in 1991, 1995, and 2000.
According to this method, the averages of 1991 and 1995
state-specific rates (1991 rate  1995 rate/2) were com-
pared with the differences between these rates (1995 rate–
1991 rate).
RESULTS
The ranges, medians, and means of the state-specific
numbers and rates of CEA procedures and deaths within 30
days in 1991, 1995, and 2000 are given in Table I. The
mean CEA rates increased from 1991 to 1995, and the
mean 30-day mortality decreased from 1991 to 1995 and
from 1995 to 2000 (P  .001). Table II shows a matrix of
correlations between 10 variables. Fig 1 shows the fre-
quency distribution of state-specific CEA rates in 1991.
These rates were closely correlated with the 1995 rates
Table I. State-specific numbers and rates of CEA and 30-day postoperative death among Medicare beneficiaries in
1991, 1995, 2000
Measure
Year
1991 1995 2000
No. of CEA procedures
Median 746 1271 1261
Range 61-4674 98-8240 126-7027
Mean (SD) 1087 (1096) 1901 (1884) 1711 (1588)
No. of 30-day deaths
Median 15 20 12
Range 0-91 1-113 1-68
Mean (SD) 20.3 (21.3) 28.1 (28.1) 16.3 (15.2)
CEA rate per 1000 beneficiaries
Median 1.80 3.18 3.05
Range 0.73-2.70 1.10-4.51 1.31-4.64
Mean (SD) 1.84 (0.50) 3.13 (0.70) 3.05 (0.69)
30-day mortality per 100 procedures
Median 1.87 1.47 0.87
Range 0.0-9.02 0.41-2.17 0.17-2.01
Mean (SD) 1.95 (1.23) 1.44 (0.36) 0.89 (0.40)
CEA, Carotid endarterectomy.
JOURNAL OF VASCULAR SURGERY
October 2003780 Sheikh and Bullock
(Fig 2, online only). The averages of the state-specific CEA
rates in 1991 and in 1995 were also correlated with their
differences (r  0.45, P  .0013), indicating that signifi-
cant correlation between 1991 and 1995 rates persisted
after the effect of regression to the mean was removed. The
increase in CEA rates from 1991 to 1995 (between 22%
and 175%) occurred in all 49 states. However, the percent
increases in these rates were inversely correlated with the
1991 rates (Fig 3, online only).
The range and the mean of the state-specific CEA rates
in 2000 were similar to that of the 1995 rates. The CEA
rates in 2000 were also closely correlated with the 1991 and
1995 rates (Fig 4, online only). However, 1995 and 2000
rates were not correlated after the effect of regression to the
mean was removed (r  0.01, P  .946). From 1995 to
2000, CEA rates increased (up to 22%) in 22 states. In the
remaining 27 states, these rates decreased between 0.3%
and 21%. These changes were unrelated to the 1995 rates.
Fig 5 shows that the percent changes in CEA rates from
1991 to 1995 were inversely correlated with those from
1995 to 2000. Furthermore, there were wide variations in
these percent changes between individual states.
Fig 6 shows the frequency distribution of the state-
specific 30-day mortality rates in 1991. The variation in and
the mean of 30-day mortality rates were lower in subse-
quent years (Table I). These state-specific rates in 1991,
1995, and in 2000 were not interrelated. From 1991 to
1995 and from 1995 to 2000, 30-day mortality increased
in some states and decreased in others; the percent changes
in the two periods were inversely correlated (Fig 7). Table
II shows that the percent change in mortality from 1991 to
1995 was inversely correlated with the mortality rates in
1991 (Fig 8, online only) and positively correlated with the
mortality rates in 1995. The percent change in mortality
from 1995 to 2000 was also inversely correlated with the
mortality rates in 1995 (Fig 9, online only) and positively
correlated with the mortality rates in 2000.
Stroke mortality in the state-specific general population
in 1991 was correlated with CEA rates in 1991 (r  0.39,
P  .0057) and was inversely correlated with percent
change in CEA rates from 1991 to 1995 (r  –0.42, P 
.0029) in the same state. Stroke mortality in the state-
specific general population in 1999 was also correlated with
CEA rates in 2000 (r  0.45, P  .0012) and percent
change in CEA rates from 1995 to 2000 (r  0.53, P 
.0001) in the same state.
DISCUSSION
There were wide variations between states with respect
to CEA rates and 30-day mortality, and the changes in
these rates over time. There was as much as a fourfold
difference between state-specific CEA rates in a year. There
was even greater (6- to 37-fold) variation between states
with respect to 30-day mortality in any given year. A recent
Table II. Correlation between state-specific carotid endarterectomy and 30-day mortality rates for Medicare
beneficiaries: United States, 1991-2000
1991 1995 2000 Percent change in rate
CEA Mortality
CEA rate Mortality CEA rate Mortality CEA rate Mortality 1991-1995 1995-2000 1991-1995
1991
Mortality 0.030
(0.839)
1995
CEA rate 0.786
(.000)
0.090
(.540)
Mortality 0.096
(.513)
0.202
(.163)
0.142
(.330)
2000
CEA rate 0.807
(.000)
0.014
(.926)
0.868
(.000)
0.028
(.847)
Mortality 0.136
(.352)
0.054
(.712)
0.175
(.229)
0.111
(.448)
0.222
(.126)
Percent change
CEA rate
1991-1995 0.536
(.000)
0.209
(.149)
0.003
(.986)
0.008
(.955)
0.161
(.271)
0.074
(.614)
1995-2000 0.005
(.971)
0.203
(.162)
0.249
(.084)
0.250
(.084)
0.188
(.196)
0.083
(.569)
0.406
(.004)
Mortality
1991-1995 0.003
(.984)
0.723
(.000)
0.060
(.684)
0.415
(.003)
0.004
(.980)
0.077
(.599)
0.037
(.801)
0.049
(.737)
1995-2000 0.115
(.432)
0.049
(.739)
0.205
(.159)
0.626
(.000)
0.131
(.368)
0.796
(.000)
0.015
(.917)
0.100
(.493)
0.351
(.013)
P value for correlation coefficients in parentheses.
CEA, carotid endarterectomy.
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Canadian study found a much larger geographic variation
in CEA rates.19 In 23 counties of a state, a wide variation in
the rates was not explained by the differences in the appro-
priateness of the use of CEA procedure.20 The CEA rate in
a geographic area is likely to be dependent on the preva-
lence of carotid stenosis, screening for asymptomatic steno-
sis, the referral practice for surgery, patient preferences, and
access to surgical services in that area. However, the varia-
tion in state-specific CEA rates was so large that the differ-
ences in the prevalence of carotid stenosis could not fully
explain it, if the prevalence was known. Some of this
variation is probably due to the differences in screening for
asymptomatic but operable carotid stenosis, or to the dif-
ferences in referral practice. Other reasons for variation in
CEA rates may include different interpretation of the clin-
ical guidelines, acceptance of the results of clinical trials of
CEA, and overuse or underuse of the procedure.
The results show that the states with relatively low CEA
rates in 1991 also had low rates in 1995, even though the
percent increase in the rate from 1991 to 1995 was higher
in these states than in the states with high baseline CEA
rates. These findings suggest that the states with low CEA
rates did not have sufficient increase to catch up with the
high-rate states by 1995, but that they were prone to
Fig 5. Correlation between state-specific change in carotid-
endarterectomy (CEA) procedures per 1000 Medicare beneficia-
ries, 1991 to 1995 and 1995 to 2000 (r  0.41; P  .0038).
Fig 1. State-specific carotid endarterectomy rate for Medicare beneficiaries, 1991.
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experience a higher increase in the subsequent 5 years. It
may be that the states with relatively high CEA rates in
1991 had less room for further increase in the rates from
1991 to 1995, the period of 70% average increase, whereas
from 1995 to 2000 CEA rates increased in some states but
not in others. This perhaps was the most likely explanation
for no correlation between these changes in CEA rates and
the baseline (1995) rates.
The states with relatively high 30-day mortality in 1991
had lower percent increase or greater percent decrease in
the rate from 1991 to 1995. For example, mortality in
1991 and the decrease in mortality from 1991 to 1995 were
highest in the states of Hawaii and Idaho. It may be that a
relatively high surgical mortality in a state prompted actions
to improve medical care and reduce this adverse outcome.
Similarly, the states with high 30-day mortality in 1995
appeared to have lower percent increase or greater percent
decrease in the rate from 1995 to 2000. Interestingly, states
with a relatively greater decrease in 30-day mortality from
1991 to 1995 had lower decrease in the subsequent 5 years.
This finding suggests that there may be a threshold beyond
which surgical mortality can not be further reduced. The
state-specific CEA rates in each year or increments in these
rates over time were not related to any measure of surgical
Fig 7. Correlation between state-specific change in 30-day post-
operative deaths per 100 procedures in Medicare beneficiaries,
1991 to 1995 and 1995 to 2000 (r  –0.35; P  .0133).
Fig 6. State-specific 30-day postprocedure mortality for Medicare beneficiaries, 1991.
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mortality, although an increase in CEA rates was expected
to be associated with lower surgical mortality. Relatively
small variations in state-specific 30-day mortality in 1995
and 2000 may be a reason for this finding.
The highest CEA rates were in the northwest corner of
United States, the Midwest, and the “stroke belt” in the
South. Although the level of stroke mortality in the general
population of a state could be regarded as a crude measure
of the need for CEA, it was correlated with the CEA rate in
the state. However, there was a relatively lower increase in
CEA rates from 1991 to 1995 in the states with high stroke
mortality in 1991. This finding suggests that either the
stroke mortality in the general population was not a valid
measure of the need for CEA in some states, or the need
was unmet in these states. Future studies using clinical data
on individual patients may explain these correlations.
The proportion of beneficiaries enrolled in the man-
aged care sector of Medicare in 1991, 1995, and 2000 were
5.8%, 10.0%, and 17.3%, respectively. Since there are no
data to suggest differences between the two sectors in use
of CEA, and since almost all US citizens aged 65 years and
older were enrolled in Medicare, the results of this study
can be generalized to the US population aged 65 years and
older. The measures of variation and correlation between
states are likely to have been distorted by the extreme values
of CEA procedures and deaths in a year. For example, the
wide standard deviation for the mean of 30-day mortality
rate in 1991 was due to the fact that mortality exceeded
3.8% in only one state (8.2% in Hawaii) and was less than
0.9 % in only one state (no deaths in Wyoming). These
distortions were a function of small numbers of CEA pro-
cedures per year in a few states.
This study suggests that the interstate variation in CEA
rates has not changed since 1995 but that variation in
30-day mortality has decreased, and that there has been a
progressive decline in mortality in all states combined dur-
ing 1991 through 2000. The overall 30-day mortality was
reduced by more than 50% during this period. Some of
these measures in different time periods were interrelated.
Further research is needed to better explain variations
between states. In the absence of disease registries, clinical
data could be used to estimate the state-specific prevalence
of carotid stenosis. This measure could then be used as the
denominator of state-specific “true” rates of CEA. The
precision of these rates could be improved by using data on
the symptoms and extent of carotid stenosis and the criteria
for selecting patients for CEA. Measures to reduce variation
may promote appropriate use of CEA procedure and im-
prove the quality of care.
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